gmp-verlag.de
 

Never ever a 483?

We can not promise that you will never get a 483
but we know that the GMP MANUAL includes all 
procedures and processes you need to be
GMP compliant.
 
Shopping cart
Your shopping cart is empty

Show shopping cart...
 
 
PDA Parenterals Conference

From 26-28 October, 2010 the PDA Parenterals Conference will be held in Berlin.

This outstanding event will cover the very important topics:

  • Future of Parenterals
  • Packaging and Impact on Quality
  • Manufacturing Flexibility and Control
  • Innovative Plants
  • Monitoring Technologies
  • Medical and Application Devices
  • Regulatory Trends

Don´t miss this interesting conference in Berlin, Germany.

Brochure of PDA Parenterals Conference 2010, October 26-28

 

News about GMP/cGMP

CAPA: Important and Necessary for Devices

On Feburary 5, 2010 the FDA published a Warning Letter, adressed to a manufacturer of medical devices (automated external defibrillator devices). The staff failed to identify and initiate CAPA-measures.

 

There where several topics found by FDA

  • Failure to establish and maintain adequate procedures to identify all the actions needed to correct and prevent the recurrence of nonconforming products and other quality problems, as required by 21 CFR 820.100(a)(3)
  • Failure to review and evaluate all complaints to determine whether an investigation is necessary and maintain a record that includes the reason when no investigation was made, as required by 21 CFR 820.198(b)
  • Failure to establish and maintain adequate procedures to verify or validate the corrective and preventive action to ensure that such action is effective and does not adversely affect the finished device, as required by 21 CFR 820.100(a)
  • Failure to establish and maintain adequate procedures to ensure that the design requirements relating to a device are appropriate and address the intended use of the device, and include a mechanism for addressing incomplete, ambiguous, or conflicting requirements, as required by 21 CFR 820.30(c)
  • Failure to establish and maintain adequate procedures to confirm that design output meets the design input requirements, as required by 21 CFR 820.30(f).
Outcome

For more detailed information and examples check FDA's Warning Letter. Review your CAPA System!

Source:

FDA/ Warning Letter

 

Comments
No comment have jet been written about this news